SUSQUEHANNA INTERNATIONAL GROUP, LLP - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2022$12,494
-85.3%
56,869
-56.1%
0.00%
Q2 2022$85,000
-40.1%
129,397
-25.3%
0.00%
Q1 2022$142,000
-83.6%
173,223
-77.1%
0.00%
Q4 2021$864,000
-45.3%
757,750
+20.0%
0.00%
Q3 2021$1,579,000
+249.3%
631,672
+315.1%
0.00%
Q2 2021$452,000
-45.3%
152,177
-35.5%
0.00%
Q1 2021$827,000
-86.1%
235,761
-81.1%
0.00%
Q4 2020$5,930,000
+230.5%
1,248,652
+238.2%
0.00%
Q3 2020$1,794,000
+109.3%
369,256
+40.0%
0.00%
Q2 2020$857,000263,7640.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders